nk3201 has been researched along with Hyperplasia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, K; Ishida, K; Jin, D; Kamoshita, K; Miyazaki, M; Sakaguchi, M; Sakonjo, H; Sukenaga, Y; Takai, S | 1 |
| Jin, D; Katsuoka, Y; Miyazaki, M; Muramatsu, M; Okamoto, Y; Sakaguchi, M; Shibahara, N; Takai, S; Ueda, H | 1 |
| Furubayashi, K; Jin, D; Kishi, K; Miyazaki, M; Muramatsu, M; Takai, S; Tamai, H | 1 |
3 other study(ies) available for nk3201 and Hyperplasia
| Article | Year |
|---|---|
A novel chymase inhibitor, 2-(5-formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[[,4-dioxo-1-phenyl-7-(2-pyridyloxy)]2-heptyl]acetamide (NK3201), suppressed intimal hyperplasia after balloon injury.
Topics: Acetamides; Animals; Carotid Artery, Common; Catheterization; Chymases; Dogs; Hyperplasia; Pyrimidines; Serine Endopeptidases; Serine Proteinase Inhibitors; Tunica Intima | 2003 |
Effect of chymase inhibition on the arteriovenous fistula stenosis in dogs.
Topics: Acetamides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arteriovenous Shunt, Surgical; Brachial Artery; Chymases; Constriction, Pathologic; Dogs; Hyperplasia; Mast Cells; Protease Inhibitors; Pyrimidines; Receptor, Angiotensin, Type 1; Serine Endopeptidases; Transforming Growth Factor beta; Tunica Intima; Tunica Media; Veins | 2005 |
The effects of chymase on matrix metalloproteinase-2 activation in neointimal hyperplasia after balloon injury in dogs.
Topics: Acetamides; Animals; Carotid Arteries; Catheterization; Cell Movement; Cells, Cultured; Chymases; Dogs; Enzyme Activation; Enzyme Inhibitors; Enzyme Precursors; Gelatinases; Humans; Hyperplasia; Matrix Metalloproteinase 2; Metalloendopeptidases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Pyrimidines; Tunica Intima | 2007 |